Clinical Trial Update: Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravitreal Kenalog, intravitreal Bevacizumab, and control for diffuse diabetic macular edema was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diffuse Diabetic Macular Edema | Phase 3 | Status: WITHDRAWN